GIGANUCLEASE
DEAD

Serial Number

76359549

Owner

Cellectis S.A.

Attorney

Barry L. Kelmachter

Filing Date

Jan 16, 2002

Add to watchlist:

No watchlists yet
View on USPTO

GIGANUCLEASE Trademark

Serial Number: 76359549 • Registration: 2988451

GIGANUCLEASE is a trademark filed by Cellectis S.A. on January 16, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cellectis S.A. (9 trademarks)

8 rue de la Croix
Paris 75013 , FR

Entity Type: 16

Trademark Details

Filing Date

January 16, 2002

Registration Date

August 30, 2005

Published for Opposition

June 7, 2005

Cancellation Date

September 21, 2012

Goods & Services

Pharmaceutical, veterinary, and health care products, namely polypeptides for in vivo and in vitro genetic engineering for use in the treatment of cystic fibrosis, Duchesne muscular dystrophy, and Alpha 1 antitrypsin disease; natural and engineered meganucleases and endonucleases, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site, all for use in the treatment of sickle cell anemia, X-SciD, and Rs-SciD; ready to use genomic recombination system comprised primarily of meganuclease recombination system for use in the treatment of muscular dystrophy; cells engineered by meganuclease recombination system for use in the treatment of genetic and viral disease, microorganism cultures and bacteriological preparations for use in the treatment of genetic and viral disease; chemotherapeutic preparations for use in the treatment of cancer; diagnostic preparations for clinical medical use

Chemicals, biochemical, biotechnological and bacteriological products namely, polypeptides for in vivo and invitro genetic engineering, natural and engineered meganuclease and endonuclease, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site; ready to use genomic recombination system comprised primarily of reagents for scientific use; cells engineered by meganuclease recombination systems for scientific research use and therapeutic use, chemical agents, biochemical, biotechnologic and bacteriological products for use in scientific research laboratories and control laboratories namely cells, reagents, and culture media; diagnostic reagents for scientific use; proteins for use in scientific research; biotechnological preparations used as molecular scissors in scientific research

Scientific and industrial research; research for others in genetic, medical, pharmaceutical, and veterinary fields; research for others in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis services, research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques, research and development of new molecules intended for industry, scientific laboratory services; conducting scientific research studies relating to engineering, natural, and engineered meganuclease and endonuclease, and meganuclease recombination systems; licensing of patents and of intellectual property; computer programming for others; and development for others of software programs and multimedia products

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 21, 2012 C8..
EXPARTE APPEAL TERMINATED
Aug 30, 2005 EXPT
REGISTERED-PRINCIPAL REGISTER
Aug 30, 2005 R.PR
PUBLISHED FOR OPPOSITION
Jun 7, 2005 PUBO
NOTICE OF PUBLICATION
May 18, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 18, 2005 PREV
ASSIGNED TO LIE
Feb 15, 2005 ALIE
ASSIGNED TO LIE
Jan 31, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2005 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 13, 2004 JURT
PAPER RECEIVED
Aug 10, 2004 MAIL
EX PARTE APPEAL-INSTITUTED
Aug 10, 2004 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Aug 4, 2004 EXAF
PAPER RECEIVED
Jul 28, 2004 MAIL
FINAL REFUSAL MAILED
Jan 26, 2004 CNFR
CASE FILE IN TICRS
Nov 20, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2003 CRFA
PAPER RECEIVED
Oct 24, 2003 MAIL
LETTER OF SUSPENSION MAILED
Jul 23, 2003 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2003 CRFA
PAPER RECEIVED
Apr 7, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2003 CRFA
PAPER RECEIVED
Mar 14, 2003 MAIL
LETTER OF SUSPENSION MAILED
Mar 7, 2003 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2002 CRFA
PAPER RECEIVED
Dec 11, 2002 MAIL
NON-FINAL ACTION MAILED
Jun 19, 2002 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2002 CRFA
PAPER RECEIVED
Mar 26, 2002 MAIL